CONMED (NYSE:CNMD) Price Target Lowered to $77.00 at Wells Fargo & Company
CONMED (NYSE:CNMD – Free Report) had its price target reduced by Wells Fargo & Company from $98.00 to $77.00 in a report published on Thursday, Benzinga reports. They currently have an equal weight rating on the stock. Several other research firms have also recently weighed in on CNMD. Piper Sandler decreased their price target on […]
More Stories
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The...
Pool (NASDAQ:POOL) Stock Rating Upgraded by StockNews.com
Pool (NASDAQ:POOL – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating...
StockNews.com Downgrades Meritage Homes (NYSE:MTH) to Sell
Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a...
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a note...
PriceSmart (NASDAQ:PSMT) Cut to Hold at StockNews.com
StockNews.com downgraded shares of PriceSmart (NASDAQ:PSMT – Free Report) from a buy rating to a hold rating in a research...
Clearfield (NASDAQ:CLFD) Rating Lowered to “Sell” at StockNews.com
Clearfield (NASDAQ:CLFD – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell”...